Skip Navigation

Our Kidney Cancer Specialists

  • Front row left to right: Joaquim Bellmunt, MD, Lauren Harshman, MD, Rana McKay, MD, Wanling Xie, MS (statistician), Meghara Walsh, RN (Research Nurse) 
Back row left to right: Laurence Albiges, MD (Visiting Scientist), Megan Lampron, BA (Clinical Research Coordinator), Katie Krajewski, MD (Radiology), Toni K. Choueiri, MD (Kidney Cancer Center Director), Laurie Appleby, NP, Marina D. Kaymakcalan (Clinical Pharmacist), Andre Fay, MD (Visiting Scientist)

    The Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) Kidney Cancer team is composed of leaders in the field who are committed to providing you with the highest level of patient care. Our multidisciplinary team of medical oncologists, urologists, radiologists, nurses, pharmacists, pathologists, and clinical research coordinators has many years of experience in the management of kidney cancer, employing the most innovative treatment options available in the world. For kidney cancer alone, our team cares for hundreds of new patients per year, and has thousands of patients who had follow-up since 2000.

    The DF/BWCC Kidney Cancer Team is at the forefront of kidney cancer research, and is one of the world's leading groups researching and publishing in kidney cancer. Our research includes testing new drugs where approved drugs have failed, tackling rare subtypes of kidney cancer, genome sequencing, as well as developing a strong interface between basic scientists and epidemiologists. Clinical trials with targeted therapy, immunotherapy, and other modalities are used for high-risk and advanced-stage patients. We also use minimally-invasive and robotic procedures as well as ablation procedures for some of our patients.

    Patients coming to DF/BWCC benefit from state-of-the-art facilities, research, and advanced care available only at one of the largest academic medical centers dedicated to kidney cancer. Experience makes a difference in caring for kidney cancer, and we are frequently asked for second opinions from the oncology community all around the country to allow patients to tap into our wealth of kidney cancer experience.

    Having specialists from multiple disciplines involved in your care ensures that all feasible approaches to treatment will be considered, and that you will receive the combination of treatments that is best for you.


    Director of the Kidney Cancer Treatment Center

    Toni K. Choueiri, MD (Medical Oncology)